Kerry Group (KRZ) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
29 Jul, 2026Strategic growth drivers and market opportunity
Focus on food service, emerging markets, and renovation as primary growth drivers, leveraging deep taste and biotechnology capabilities and a global innovation ecosystem.
Consistent outperformance of end-markets, with 3.8% average volume growth and 320 basis points of EBITDA margin expansion over four years.
Portfolio transformation to a pure play taste and nutrition company, expansion into emerging markets, and investment in next-generation technologies.
Addressable market expected to exceed EUR 100 billion within the decade, driven by innovation, renovation, and regulatory trends.
Differentiated capabilities in taste and biotechnology, supported by over €3 billion investment in science and technology, enable value creation for customers.
Financial performance and 2030 targets
Volume growth targeted at 3%-5%, with regional expectations: Americas 3%-5%, Europe 1%-2%, APMEA 5%-9%.
EBITDA margin goal set at 20%-21% by 2030, supported by operating leverage, product mix, and efficiency initiatives.
High-single-digit plus constant currency EPS growth and increased cash conversion target to 85%.
Return on capital employed target raised to 12%-13% by 2030, with EUR 3.5 billion free cash flow expected from 2027-2030.
Capital allocation priorities remain: reinvestment, dividends, strategic M&A, and share buybacks.
Innovation, renovation, and operational excellence
Renovation is a structural market shift, with key areas including sodium reduction, protein enhancement, and clean label solutions; product renovation accounts for ~40% of the pipeline.
Integrated technology solutions and digital and AI initiatives drive efficiency, supply chain optimization, customer experience, and agile product innovation.
Accelerate 2.0 program focuses on footprint optimization, digital excellence, and operating leverage.
R&D investment exceeds EUR 300 million, focused on new innovations in taste and biotechnology.
Digital excellence and operational optimization programs are driving efficiency and supporting growth ambitions.
Latest events from Kerry Group
- EBITDA margin rose to 16.7% on 3.3% volume growth, with ambitious 2030 targets set.KRZ
Q2 2026 & Status update31 Jul 2026 - EBITDA margin rose to 16.7% on 3.3% volume growth, with strong cash flow and upgraded 2030 targets.KRZ
Q2 2026 Pre recorded29 Jul 2026 - Margin expansion to 19–20% by 2026, led by innovation, high-growth channels, and a €300m buyback.KRZ
Investor Day 202415 May 2026 - Q1 2026 delivered 3.1% volume growth, 60bps margin expansion, and held EPS guidance despite FX headwinds.KRZ
Q1 202630 Apr 2026 - Sustainable nutrition, innovation, and strong financials drive global growth and ESG leadership.KRZ
Investor presentation19 Mar 2026 - Innovation, digital excellence, and disciplined growth drive strong financial and sustainability results.KRZ
Consumer Analyst Group of New York Conference (CAGNY) 202620 Feb 2026 - Strong volume and EPS growth, margin expansion, and innovation investments drive outlook.KRZ
Q4 202517 Feb 2026 - Upgraded EPS guidance, strong margin expansion, and robust T&N growth drive H1 outperformance.KRZ
Q2 20242 Feb 2026 - Q3 saw strong volume and margin growth, with full-year EPS guidance reaffirmed.KRZ
Q3 202418 Jan 2026